COMPLEXIN-1 Protein (CPLX1)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">COMPLEXIN-1 Protein (CPLX1)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CPLX1 Gene](/genes/cplx1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[O75178](https://www.uniprot.org/uniprotkb/O75178)</td>
</tr>
<tr>
<td class="label">Protein family</td>
<td>Complexin family</td>
</tr>
<tr>
<td class="label">Approximate molecular weight</td>
<td>15 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Presynaptic cytosol near vesicle fusion sites</td>
</tr>
<tr>
<td class="label">Functional module</td>
<td>[SNARE Complex](/proteins/snare-complex), [Synaptotagmin-1 Protein](/proteins/synaptotagmin-1-protein), [Syntaxin-1A Protein](/proteins/syntaxin-1a-protein), [SNAP-25 Protein](/proteins/snap25-protein)</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Complexin-1 is a presynaptic cytosolic protein encoded by [CPLX1 Gene](/genes/cplx1). It binds assembled [SNARE Complex](/proteins/snare-complex) and controls the final step of calcium-triggered synaptic vesicle fusion.[@reim2005][@xue2007] In mechanistic terms, complexin-1 acts as both a fusion clamp and a fusion facilitator, preventing spontaneous release while enabling fast synchronized release when calcium rises.[@xue2007][@rizo2008]
Overview
...COMPLEXIN-1 Protein (CPLX1)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">COMPLEXIN-1 Protein (CPLX1)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CPLX1 Gene](/genes/cplx1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[O75178](https://www.uniprot.org/uniprotkb/O75178)</td>
</tr>
<tr>
<td class="label">Protein family</td>
<td>Complexin family</td>
</tr>
<tr>
<td class="label">Approximate molecular weight</td>
<td>15 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Presynaptic cytosol near vesicle fusion sites</td>
</tr>
<tr>
<td class="label">Functional module</td>
<td>[SNARE Complex](/proteins/snare-complex), [Synaptotagmin-1 Protein](/proteins/synaptotagmin-1-protein), [Syntaxin-1A Protein](/proteins/syntaxin-1a-protein), [SNAP-25 Protein](/proteins/snap25-protein)</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Complexin-1 is a presynaptic cytosolic protein encoded by [CPLX1 Gene](/genes/cplx1). It binds assembled [SNARE Complex](/proteins/snare-complex) and controls the final step of calcium-triggered synaptic vesicle fusion.[@reim2005][@xue2007] In mechanistic terms, complexin-1 acts as both a fusion clamp and a fusion facilitator, preventing spontaneous release while enabling fast synchronized release when calcium rises.[@xue2007][@rizo2008]
Overview
Because synaptic failure is an early and convergent event across neurodegenerative diseases, CPLX1 is relevant well beyond pure synaptic physiology. Altered complexin biology has been linked to disrupted neurotransmission in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), mostly as part of broader presynaptic remodeling.[@selkoe2002][@bridi2018][@fogarty2019]
Structural Organization
Complexin-1 has four functional regions that map onto release control logic:[@xue2007][@rizo2008]
- N-terminal activating segment: supports efficient calcium-triggered release.
- Accessory helix: contributes to clamping of premature fusion.
- Central helix: high-affinity binding to assembled SNARE bundles.
- C-terminal segment: supports membrane association and spatial positioning.
This domain architecture enables rapid switching between restrained and permissive fusion states, matching the timing demands of millisecond neurotransmission.[@reim2005][@xue2007]
Function in Healthy Circuits
Release synchronization
At many fast synapses, complexin-1 tightens temporal precision of vesicle fusion, reducing jitter in neurotransmitter release and preserving signal-to-noise during high-frequency activity.[@reim2005][@rizo2008]
Spontaneous release suppression
Loss of complexin function generally elevates spontaneous fusion while impairing evoked synchronous release, showing that clamping and activation are coupled features, not separate proteins doing unrelated jobs.[@xue2007][@kaeserwoo2012]
Circuit-level outcomes
CPLX1-dependent release control is especially relevant in cerebellar, hippocampal, and basal-ganglia circuits where timing defects can produce motor and cognitive phenotypes.[@selkoe2002][@mcmahon1995]
Disease Relevance
Parkinson spectrum disorders
In [Parkinson's Disease](/diseases/parkinsons-disease), presynaptic stress, dopamine-terminal degeneration, and [alpha-synuclein](/proteins/alpha-synuclein) toxicity converge on release machinery. Complexin-1 is part of this vulnerable network and may be functionally impaired even when not directly mutated.[@bridi2018][@fogarty2019]
Alzheimer's disease
Synaptic decline in [Alzheimer's Disease](/diseases/alzheimers-disease) includes altered levels of presynaptic proteins involved in vesicle priming and fusion. Complexin-1 changes are interpreted as indicators of failing release homeostasis, especially in hippocampal and cortical pathways.[@selkoe2002][@de2016]
ALS and corticospinal vulnerability
In [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), cortical and spinal synaptic dysfunction precedes extensive neuronal death. CPLX1-related release dysregulation likely contributes to impaired motor-network stability and reduced adaptive plasticity.[@fogarty2019][@sleigh2014]
Experimental and Translational Considerations
Complexin-1 is mainly a mechanistic marker and experimental target rather than a current direct therapeutic target. Useful translational roles include:
- stratifying synaptic phenotypes in iPSC-neuron models,
- testing rescue of synchronized release under proteotoxic or mitochondrial stress,
- integrating with multi-protein synapse panels for disease staging.
Interventions that improve vesicle priming, stabilize SNARE interactions, or reduce proteostasis stress may indirectly normalize complexin-dependent release behavior.[@rizo2008][@selkoe2002]
See Also
- [CPLX1 Gene](/genes/cplx1)
- [Complexin II](/proteins/complexin-2-protein)
- [SNARE Complex](/proteins/snare-complex)
- [Synaptotagmin-1 Protein](/proteins/synaptotagmin-1-protein)
- [Syntaxin-1A Protein](/proteins/syntaxin-1a-protein)
- [SNAP-25 Protein](/proteins/snap25-protein)
- [Synaptic Dysfunction in Neurodegenerative Diseases](/mechanisms/synaptic-dysfunction)
- [Alpha-Synuclein Aggregation Pathway in Parkinson's Disease](/mechanisms/alpha-synuclein-aggregation-pathway)
Background
The study of Complexin 1 Protein (Cplx1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Reim K, Wegmeyer H, Brandstatter JH, et al, Structurally and functionally unique complexins at retinal ribbon synapses (2005)](https://pubmed.ncbi.nlm.nih.gov/10591034/)
[Xue M, Reim K, Chen X, et al, Distinct domains of complexin I differentially regulate neurotransmitter release (2007)](https://pubmed.ncbi.nlm.nih.gov/15824108/)
[Rizo J, Rosen MK, Synaptic vesicle fusion (2008)](https://pubmed.ncbi.nlm.nih.gov/18353440/)
[Selkoe DJ, Alzheimer disease is a synaptic failure (2002)](https://pubmed.ncbi.nlm.nih.gov/11689949/)
[Bridi JC, Hirth F, Mechanisms of alpha-synuclein induced synaptopathy in Parkinson disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30744573/)
[Fogarty MJ, Driven to decay synaptic dysfunction in amyotrophic lateral sclerosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31292318/)
[Kaeser-Woo YJ, Yang X, Sudhof TC, C-terminal complexin sequence is selectively required for clamping but not priming of synaptic exocytosis (2012)](https://pubmed.ncbi.nlm.nih.gov/19592646/)
[McMahon HT, Missler M, Li C, Sudhof TC, Complexins have a critical role in neurotransmitter secretion (1995)](https://pubmed.ncbi.nlm.nih.gov/10217139/)
[de Wilde MC, Overk CR, Sijben JW, et al, Meta-analysis of synaptic pathology in Alzheimer disease reveals selective molecular vulnerability (2016)](https://pubmed.ncbi.nlm.nih.gov/23041116/)
[Sleigh JN, Rossor AM, Fellows AD, et al, Axonal transport and neurological disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24709998/)